AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
BESIFLOXACINE
4 registrations across 3 African markets— 3 active
Markets with BESIFLOXACINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| BESIVANCE 0,6% SUSPENSION OPHTALMIQUE FLACON DE 5ML | 🇨🇮Côte d'Ivoire | LABORATOIRES BAUSCH&LOMB INCORPORATED | expired | Feb 2024 |
| BESIVANCE® SUSP OPHT BTE (1 FL X 5 ML) BAUSCH & LOMB suspension ophtalmique, boîte | 🇲🇬Madagascar | BAUSCH & LOMB | active | — |
| BESIVANCE® SUSP OPHT BTE (1 FL X 5 ML) BAUSCH & LOMB suspension ophtalmique, boîte | 🇲🇬Madagascar | BAUSCH & LOMB | active | — |
| BESIVANCE collyre / 0,6 % | 🇸🇳Senegal | BAUSCH/LOMB INCORPORATED | active | — |
BESIFLOXACINE in Africa — Regulatory Overview
BESIFLOXACINE is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Madagascar, Côte d'Ivoire, Senegal. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 3 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.